Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study.
Lopes SS, Pericot-Valverde I, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Karasz A, Arnsten J, Moschella P, Heo M, Litwin AH. Lopes SS, et al. Among authors: arnsten j. BMC Infect Dis. 2024 Feb 23;24(1):251. doi: 10.1186/s12879-024-09124-3. BMC Infect Dis. 2024. PMID: 38395747 Free PMC article.
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs.
Tsui JI, Lum PJ, Taylor LE, Mehta SH, Feinberg J, Kim AY, Norton BL, Niu J, Heo M, Arnsten J, Pericot-Valverde I, Thomas A, Blalock KL, Radick A, Murray-Krezan C, Page K, Litwin AH; HERO Study Group. Tsui JI, et al. Among authors: arnsten j. Drug Alcohol Depend. 2023 Jun 1;247:109878. doi: 10.1016/j.drugalcdep.2023.109878. Epub 2023 Apr 17. Drug Alcohol Depend. 2023. PMID: 37150144 Clinical Trial.
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study.
Pericot-Valverde I, Lopes SS, Nahvi S, Thrasher JF, Karasz A, Taylor LE, Mehta SH, Lum PJ, Tsui JI, Page K, Feinberg J, Kim AY, Norton BL, Arnsten JH, Fernandez-Artamendi S, Heo M, Litwin A; HERO Research Group. Pericot-Valverde I, et al. Among authors: arnsten jh. Open Forum Infect Dis. 2023 Oct 5;10(11):ofad498. doi: 10.1093/ofid/ofad498. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023556 Free PMC article.
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study.
Lopes SS, Pericot-Valverde I, Arnsten J, Lum PJ, Taylor LE, Mehta SH, Tsui JI, Feinberg J, Kim AY, Norton BL, Page K, Murray-Krezan C, Anderson J, Moschella P, Heo M, Litwin AH. Lopes SS, et al. Among authors: arnsten j. Int J Drug Policy. 2024 Jan;123:104288. doi: 10.1016/j.drugpo.2023.104288. Epub 2023 Dec 15. Int J Drug Policy. 2024. PMID: 38103458 Clinical Trial.
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.
Heo M, Norton BL, Pericot-Valverde I, Mehta SH, Tsui JI, Taylor LE, Lum PJ, Feinberg J, Kim AY, Arnsten JH, Sprecht-Walsh S, Page K, Murray-Krezan C, Anderson J, Litwin AH; HERO Study Group. Heo M, et al. Among authors: arnsten jh. J Hepatol. 2024 May;80(5):702-713. doi: 10.1016/j.jhep.2023.12.020. Epub 2024 Jan 17. J Hepatol. 2024. PMID: 38242324
Predictors of sharing injection equipment by HIV-seropositive injection drug users.
Latkin CA, Buchanan AS, Metsch LR, Knight K, Latka MH, Mizuno Y, Knowlton AR; Intervention for Seropositive Injectors--Research Evaluation Team. Latkin CA, et al. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):447-50. doi: 10.1097/qai.0b013e31818a6546. J Acquir Immune Defic Syndr. 2008. PMID: 19186356 Free PMC article.
200 results